This is consistent with findings in other series of well differentiated thyroid cancer, where BRAF mutations in tumors>1 cm in size and particularly co-occurring BRAF and TERT mutations were associated with a significantly higher risk of disease recurrence16,17. The gene discussed is BRAF; the disease is thyroid cancer.